Submitted by Anonymous (not verified) on 8 September 2023 - 8:03
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Idiopathic Pulmonary Fibrosis;Lung Diseases;Respiratory Tract Diseases, Date of authorisation: 27/02/2011, Revision: 33, Status: Authorised
Source: